• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲水性 HYNIC-[1,2,4,5]四嗪缀合物的合成及其在 Tc 标记抗体前靶向中的应用。

Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with Tc.

机构信息

Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Mataojo 2055, 11400 Montevideo, Uruguay.

出版信息

Org Biomol Chem. 2018 Jul 25;16(29):5275-5285. doi: 10.1039/c8ob01255e.

DOI:10.1039/c8ob01255e
PMID:29974915
Abstract

Pretargeted imaging, based on the highly reactive process between [1,2,4,5]tetrazines with trans-cyclooctene (TCO), appears as an attractive strategy to overcome disadvantages associated with traditional radioimmunoconjugates. To be successful, the radiolabeled component should react in vivo with the conjugated antibody and the non reactive excess clear fast from the organism. Herein, we explore the in vivo effects of hydrophilic linker incorporation into [1,2,4,5]tetrazine systems bearing a 6-hydrazinonicotinyl (HYNIC) moiety for technetium-99m coordination. Incorporation of a polypeptide chain containing hydrophilic aminoacids, resulted in a derivative with renal clearance. Pretargeted bevacizumab imaging was used as proof of concept.

摘要

基于[1,2,4,5]四嗪与反式环辛烯(TCO)之间的高反应性,前靶向成像似乎是克服传统放射性免疫偶联物相关缺点的一种有吸引力的策略。为了成功,放射性标记的部分应该在体内与共轭抗体反应,并且未反应的多余部分快速从生物体中清除。在此,我们研究了将含有亲水性氨基酸的多肽链引入带有 6-肼基烟酰基(HYNIC)部分的[1,2,4,5]四嗪系统中对锝-99m 配位的体内影响。亲水性氨基酸的多肽链的引入导致了具有肾清除率的衍生物。贝伐单抗的前靶向成像被用作概念验证。

相似文献

1
Synthesis of hydrophilic HYNIC-[1,2,4,5]tetrazine conjugates and their use in antibody pretargeting with Tc.亲水性 HYNIC-[1,2,4,5]四嗪缀合物的合成及其在 Tc 标记抗体前靶向中的应用。
Org Biomol Chem. 2018 Jul 25;16(29):5275-5285. doi: 10.1039/c8ob01255e.
2
Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.具有改进性质的反式环辛烯标记物,用于通过狄尔斯-阿尔德反应进行肿瘤预靶向。
Mol Pharm. 2014 Sep 2;11(9):3090-6. doi: 10.1021/mp500275a. Epub 2014 Aug 13.
3
Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted Chemistry.亲脂性和点击反应活性决定了生物正交四嗪工具在前靶向化学中的性能。
ACS Pharmacol Transl Sci. 2021 Feb 16;4(2):824-833. doi: 10.1021/acsptsci.1c00007. eCollection 2021 Apr 9.
4
(99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.用于体内预靶向成像的(99m)锝生物正交点击化学试剂
Bioorg Med Chem. 2016 Mar 15;24(6):1209-15. doi: 10.1016/j.bmc.2016.01.046. Epub 2016 Jan 29.
5
A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives.一种用于生物正交化学的99mTc标记四嗪。与小分子反式环辛烯衍生物的合成及生物分布研究。
PLoS One. 2016 Dec 9;11(12):e0167425. doi: 10.1371/journal.pone.0167425. eCollection 2016.
6
Diabody Pretargeting with Click Chemistry In Vivo.体内点击化学介导的双抗体预靶向
J Nucl Med. 2015 Sep;56(9):1422-8. doi: 10.2967/jnumed.115.159145. Epub 2015 Jul 9.
7
In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.基于半胱氨酸选择性抗体修饰的体内前靶向与 IEDDA 生物正交连接用于点击化学。
Bioconjug Chem. 2021 Jan 20;32(1):121-132. doi: 10.1021/acs.bioconjchem.0c00551. Epub 2020 Dec 9.
8
A Bone-Seeking trans-Cyclooctene for Pretargeting and Bioorthogonal Chemistry: A Proof of Concept Study Using Tc- and Lu-Labeled Tetrazines.一种用于预靶向和生物正交化学的骨靶向反式环辛烯:使用锝和镥标记的四嗪的概念验证研究
J Med Chem. 2016 Oct 27;59(20):9381-9389. doi: 10.1021/acs.jmedchem.6b00938. Epub 2016 Oct 5.
9
-Cyclooctene-Functionalized PeptoBrushes with Improved Reaction Kinetics of the Tetrazine Ligation for Pretargeted Nuclear Imaging.环辛烯功能化的 Pepto 刷,提高了反式环辛烯连接的反应动力学,用于靶向核成像。
ACS Nano. 2020 Jan 28;14(1):568-584. doi: 10.1021/acsnano.9b06905. Epub 2020 Jan 2.
10
Antibody-Based In Vivo Imaging of Central Nervous System Targets-Evaluation of a Pretargeting Approach Utilizing a TCO-Conjugated Brain Shuttle Antibody and Radiolabeled Tetrazines.基于抗体的中枢神经系统靶点体内成像——利用反式环辛烯偶联脑穿梭抗体和放射性标记四嗪的预靶向方法评估
Pharmaceuticals (Basel). 2022 Nov 22;15(12):1445. doi: 10.3390/ph15121445.

引用本文的文献

1
[Ga]Ga-THP-tetrazine for bioorthogonal click radiolabelling: pretargeted PET imaging of liposomal nanomedicines.用于生物正交点击放射性标记的[镓]镓-THP-四嗪:脂质体纳米药物的预靶向正电子发射断层扫描成像
RSC Chem Biol. 2024 May 14;5(7):622-639. doi: 10.1039/d4cb00039k. eCollection 2024 Jul 3.
2
Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer.迈向肿瘤完全切除:用于改进GRPR表达前列腺癌图像引导手术的新型双模态探针
Pharmaceutics. 2022 Jan 14;14(1):195. doi: 10.3390/pharmaceutics14010195.
3
Covalent Immobilization of Antibodies through Tetrazine-TCO Reaction to Improve Sensitivity of ELISA Technique.
通过点击化学中环加成反应将抗体共价固定以提高 ELISA 技术的灵敏度。
Biosensors (Basel). 2021 Dec 20;11(12):524. doi: 10.3390/bios11120524.
4
Site-Specific and Residualizing Linker for F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment.用于 F 标记的具有增强的肾脏清除率的位点特异性和残留连接子:在抗 HER2 单域抗体片段中的应用。
J Nucl Med. 2021 Nov;62(11):1624-1630. doi: 10.2967/jnumed.120.261446. Epub 2021 Feb 26.
5
A Pretargeted Imaging Strategy for EGFR-Positive Colorectal Carcinoma via Modulation of Tz-Radioligand Pharmacokinetics.通过调节 Tz-放射性配体药代动力学实现 EGFR 阳性结直肠癌的靶向成像策略。
Mol Imaging Biol. 2021 Feb;23(1):38-51. doi: 10.1007/s11307-020-01539-z. Epub 2020 Sep 10.
6
Recent Advances in Bioorthogonal Click Chemistry for Efficient Synthesis of Radiotracers and Radiopharmaceuticals.生物正交点击化学在放射性示踪剂和放射性药物高效合成中的最新进展。
Molecules. 2019 Oct 2;24(19):3567. doi: 10.3390/molecules24193567.
7
Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.基于逆电子需求 Diels-Alder 反应的靶向核医学成像和放射免疫治疗及靶向合成设计中的关键因素。
Contrast Media Mol Imaging. 2019 Aug 25;2019:9182476. doi: 10.1155/2019/9182476. eCollection 2019.